(Q48497804)

12 February 2018

erratum

0 references

title

Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample. (English)

1 reference

12 February 2018

0 references

1 reference

5

1 reference

12 February 2018

Alexandra L Quittner

1

object named as

Alexandra L Quittner

1 reference

12 February 2018

author name string

Gregory S Sawicki

2

1 reference

12 February 2018

Ann McMullen

3

1 reference

12 February 2018

Lawrence Rasouliyan

4

1 reference

12 February 2018

Ashley Yegin

6

1 reference

12 February 2018

Michael W Konstan

7

1 reference

12 February 2018

publication date

13 January 2012

1 reference

12 February 2018

published in

Quality of Life Research

1 reference

12 February 2018

volume

21

1 reference

12 February 2018

issue

7

1 reference

12 February 2018

page(s)

1279-1290

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1007/s11136-011-0091-5

exact match

0 references

cites work

Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Patient-reported outcomes in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Systematic review of health-related quality of life measures for children with respiratory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Prevalence and impact of depression in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Gender gap in cystic fibrosis mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Predictors of mortality in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

High treatment burden in adults with cystic fibrosis: challenges to disease self-management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Validation of a Disease-Specific Measure of Health-Related Quality of Life for Children with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Mucus clearance and lung function in cystic fibrosis with hypertonic saline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Patterns of agreement between parent and child ratings of emotional and behavioral problems in an outpatient clinical setting: when children endorse more problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Assessment of agreement between parents and children on health-related quality of life in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-011-0091-5

The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22240933

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22240933

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11136-011-0091-5

1 reference

12 February 2018

PubMed ID

22240933

1 reference

12 February 2018